Battelino T, Danne T, Edelman SV, Choudhary P, et al. CGM-based Time-in-Range Using Insulin Glargine 300 Units/mL Versus Insulin Degludec 100 Units/mL in Type 1 Diabetes: The Head-to-Head Randomized Controlled InRange Trial. Diabetes Obes Metab 2022 Oct 20. doi: 10.1111/dom.14898.
PMID: 36263928